A previous study showed that GFAP-A patients had significantly higher levels of CSF CCL20 than other patients (MS, NMOSD, and psychosomatic disorders), except patients with varicella zoster virus meningitis (4). This evidence concerns the gene GFAP and myeloid sarcoma.